You have 9 free searches left this month | for more free features.

lactulose

Showing 1 - 25 of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatic Encephalopathy, Chronic Liver Disease Trial (Tap water, Lactulose)

Not yet recruiting
  • Hepatic Encephalopathy
  • Chronic Liver Disease
  • Tap water
  • Lactulose
  • (no location specified)
Apr 3, 2023

Hepatic Encephalopathy Trial in Cairo (Nifuroxazide, Lactulose)

Not yet recruiting
  • Hepatic Encephalopathy
  • Cairo, Egypt
    National Hepatology and Tropical Medicine Research Institute (NH
Feb 23, 2023

Lactulose vs Lactobacillus Acidophilus Effect in CKD Patients

Not yet recruiting
  • CKD
  • Lactulose
  • (no location specified)
Jun 28, 2023

Lactulose, Polyethylene Glycol, Bowel Preparation Trial in Montevideo (Lactulose, Polyethylene Glycol 3350)

Recruiting
  • Lactulose
  • +4 more
  • Lactulose
  • Polyethylene Glycol 3350
  • Montevideo, Uruguay
    Hospital de Clinicas
Feb 10, 2023

Hepatic Encephalopathy, Acute-On-Chronic Liver Failure Trial in Chandigarh (Branched chain amino acid, Lactulose)

Completed
  • Hepatic Encephalopathy
  • Acute-On-Chronic Liver Failure
  • Branched chain amino acid
  • Lactulose
  • Chandigarh, India
    PGIMER
Aug 14, 2022

Hepatic Encephalopathy Trial (lactulose, colistin)

Not yet recruiting
  • Hepatic Encephalopathy
  • (no location specified)
Mar 6, 2022

Liver Cirrhosis, Renal Failure Trial in New York (Rifaximin, Lactulose)

Withdrawn
  • Liver Cirrhosis
  • Renal Failure
  • New York, New York
    Weill Cornell Medical Center
Jan 24, 2022

Cirrhosis Trial in Ann Arbor (Lactulose)

Completed
  • Cirrhosis
  • Lactulose
  • Ann Arbor, Michigan
    University of Michigan
Nov 2, 2022

Cirrhosis, Liver, Portal Hypertension Trial in Ann Arbor, Philadelphia, Dallas (Enhanced Usual Care, Lactulose, Investigator

Not yet recruiting
  • Cirrhosis, Liver
  • Portal Hypertension
  • Enhanced Usual Care
  • +3 more
  • Ann Arbor, Michigan
  • +2 more
Mar 20, 2023

Hepatic Encephalopathy Trial in Karachi (Polyethylene Glycols, Lactulose)

Recruiting
  • Hepatic Encephalopathy
  • Polyethylene Glycols
  • Lactulose
  • Karachi, Sindh, Pakistan
    Aga Khan University
Jul 6, 2021

Hepatic Encephalopathy, Acute-On-Chronic Liver Failure Trial in Chandigarh (Branch Chain Amino Acid, Lactulose)

Recruiting
  • Hepatic Encephalopathy
  • Acute-On-Chronic Liver Failure
  • Branch Chain Amino Acid
  • Lactulose
  • Chandigarh, India
    Dr. Madhumita Premkumar
Jan 17, 2023

Colon Disease Trial (Lactulose, Polyethylene Glycol (PEG))

Not yet recruiting
  • Colon Disease
  • Lactulose
  • Polyethylene Glycol (PEG)
  • (no location specified)
Mar 10, 2021

Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome Trial in Shanghai (Linaclotide, Lactulose, Omeprazol)

Recruiting
  • Functional Dyspepsia
  • Constipation-predominant Irritable Bowel Syndrome
  • Shanghai, Shanghai, China
    RenJiH
Nov 29, 2021

Hepatic Encephalopathy, Liver Cirrhosis, End Stage Liver DIsease Trial (E.coli Nissle 1917, Lactulose, Rifaximin)

Completed
  • Hepatic Encephalopathy
  • +2 more
  • E.coli Nissle 1917
  • +2 more
  • (no location specified)
Mar 5, 2021

Overt Hepatic Encephalopathy Trial in United States (40 mg Rifaximin SSD once daily, 40 mg Rifaximin SSD twice daily, 80 mg

Completed
  • Overt Hepatic Encephalopathy
  • 40 mg Rifaximin SSD once daily
  • +5 more
  • Corona Del Mar, California
  • +33 more
Mar 10, 2021

Constipation - Functional Trial in Jakarta (PEG 3350, Lactulose)

Active, not recruiting
  • Constipation - Functional
  • PEG 3350
  • Lactulose
  • Jakarta, DKI Jakarta, Indonesia
  • +2 more
Oct 19, 2020

Motility Disorder of Intestine, Ondansetron, Small Bowel Water Trial in Nottingham (Ondansetron 8mg, abdominal MRI, Lactulose)

Completed
  • Motility Disorder of Intestine
  • +2 more
  • Ondansetron 8mg
  • +3 more
  • Nottingham, Nottinghamshire, United Kingdom
    University of Nottingham
Nov 26, 2019

Refractory Hepatic Encephalopathy Trial in New Delhi (Lactulose, Rifaximin, Plasmapheresis)

Withdrawn
  • Refractory Hepatic Encephalopathy
  • Lactulose
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver and Biliary Sciences
Nov 1, 2019

Hepatic Encephalopathy, Acute-On-Chronic Liver Failure Trial in Chandigarh (PEG-3350 with Electolytes, Lactulose)

Unknown status
  • Hepatic Encephalopathy
  • Acute-On-Chronic Liver Failure
  • PEG-3350 with Electolytes
  • Lactulose
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Jun 14, 2019

Hepatic Encephalopathy Trial in Miami (Rifaximin, Lactulose, Placebo)

Terminated
  • Hepatic Encephalopathy
  • Miami, Florida
    Center For Liver Diseases - University of Miami
Aug 27, 2019

Hepatic Encephalopathy, Cirrhosis Trial in United States (Rifaximin, Lactulose)

Completed
  • Hepatic Encephalopathy
  • Cirrhosis
  • Phoenix, Arizona
  • +42 more
Sep 6, 2019

Impaired Small Intestinal Permeability Trial in Rochester (12C mannitol, Indomethacin, 13C mannitol)

Completed
  • Impaired Small Intestinal Permeability
  • 12C mannitol
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2019

Liver Cirrhosis Trial in New Delhi (Nutrition, Lactulose, Diet)

Withdrawn
  • Liver Cirrhosis
  • Nutrition
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver and Biliary Sciences
Dec 8, 2018

Hepatic Encephalopathy Trial in Mexico City (Lactulose, L-ornithine L-aspartate, Rifaximin)

Completed
  • Hepatic Encephalopathy
  • Lactulose
  • +3 more
  • Mexico City, Mexico
    Hospital General de Mexico
May 19, 2018

Acute-On-Chronic Liver Failure Trial in New Delhi (Lactulose + Rifaximin, Lactulose)

Completed
  • Acute-On-Chronic Liver Failure
  • Lactulose + Rifaximin
  • Lactulose
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Feb 7, 2018